Find Cepharanthine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 481-49-2, Cepharanthin, (+)-cepharanthine, O-methylcepharanoline, Cepharantin, Cepharanthine [jan]
Molecular Formula
C37H38N2O6
Molecular Weight
606.7  g/mol
InChI Key
YVPXVXANRNDGTA-WDYNHAJCSA-N
FDA UNII
7592YJ0J6T

Cepharanthine
(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2,.1,.1,.0,.0,.0,]nonatriaconta-1(34),3,8,10(39),16,18,21(36),22,24,31(35),32,37-dodecaene is a natural product found in Stephania sinica, Stephania cephalantha, and other organisms with data available.
1 2D Structure

Cepharanthine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.216,19.13,10.121,25.04,8.031,35.014,39]nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene
2.1.2 InChI
InChI=1S/C37H38N2O6/c1-38-13-11-24-18-31(41-4)33-20-27(24)28(38)16-23-7-10-30(40-3)32(17-23)44-26-8-5-22(6-9-26)15-29-35-25(12-14-39(29)2)19-34-36(37(35)45-33)43-21-42-34/h5-10,17-20,28-29H,11-16,21H2,1-4H3/t28-,29+/m1/s1
2.1.3 InChI Key
YVPXVXANRNDGTA-WDYNHAJCSA-N
2.1.4 Canonical SMILES
CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3
2.1.5 Isomeric SMILES
CN1CCC2=CC3=C(C4=C2[C@@H]1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)C[C@@H]7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3
2.2 Other Identifiers
2.2.1 UNII
7592YJ0J6T
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan

2. Cepharanthin

2.3.2 Depositor-Supplied Synonyms

1. 481-49-2

2. Cepharanthin

3. (+)-cepharanthine

4. O-methylcepharanoline

5. Cepharantin

6. Cepharanthine [jan]

7. 6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))oxyacanthan

8. Nsc-623442

9. Chebi:3546

10. 7592yj0j6t

11. Nsc623442

12. Cepharanthine (jan)

13. (14s,27r)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.216,19.13,10.121,25.04,8.031,35.014,39]nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene

14. Oxyacanthan, 6',12'-dimethoxy-2,2'-dimethyl-6,7-(methylenebis(oxy))-

15. Ecaene (non-preferred Name)

16. Dsstox_cid_25957

17. Dsstox_rid_81253

18. Dsstox_gsid_45957

19. 22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.216,19.13,10.121,25.04,8.031,35.014,39]nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene

20. Cas-481-49-2

21. Ccris 6539

22. Sr-01000779734

23. Nsc 623442

24. Brn 0075231

25. Unii-7592yj0j6t

26. Cepharanthin,(s)

27. Ncgc00095194-01

28. (14s,27r)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2~16,19~.1~3,10~.1~21,25~.0~4,8~.0~14,39~.0~31,35~]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dod

29. Cepharanthine (tn)

30. Spectrum2_000832

31. Spectrum3_001963

32. 12-o-methylcepharanoline

33. Cepharanthine [mi]

34. Upcmld-dp054

35. Bspbio_003563

36. 4-27-00-09061 (beilstein Handbook Reference)

37. Mls000728518

38. Schembl154545

39. Spectrum1505322

40. Spbio_000783

41. Cepharanthine [who-dd]

42. Chembl449782

43. Dtxsid6045957

44. Upcmld-dp054:001

45. Kbio3_002909

46. Cepharanthine, >=95% (hplc)

47. Cepharanthine, >=98% (hplc)

48. Hms1922j12

49. Hms2232f21

50. Pharmakon1600-01505322

51. Hy-n6972

52. Tox21_111483

53. Bbl030154

54. Bdbm50423643

55. Ccg-40294

56. Mfcd00210482

57. Nsc758965

58. S4238

59. Stk801907

60. Zinc30726863

61. Akos004119865

62. Tox21_111483_1

63. Nsc-758965

64. Sdccgmls-0066893.p001

65. Ncgc00161621-01

66. Ncgc00161621-02

67. Ncgc00161621-03

68. Ncgc00161621-05

69. Ncgc00161621-13

70. Ac-15206

71. As-17451

72. Smr000445632

73. Sbi-0207049.p001

74. Cs-0007138

75. M2968

76. C09391

77. D01035

78. Ab00643356_08

79. Ab00643356_09

80. 481c492

81. A871948

82. Q-100524

83. Sr-01000779734-3

84. Sr-01000779734-4

85. Brd-k96194081-001-06-0

86. Q15410888

87. (14s,27r)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2(16,19).1(3,10).1(21,25).0(4,8).0(14,39).0(31,35)]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene

88. (14s,27r)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2??,??.1?,??.1??,??.0?,?.0??,??.0??,??]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dodecaene

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 606.7 g/mol
Molecular Formula C37H38N2O6
XLogP36.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count8
Rotatable Bond Count2
Exact Mass606.27298694 g/mol
Monoisotopic Mass606.27298694 g/mol
Topological Polar Surface Area61.9 Ų
Heavy Atom Count45
Formal Charge0
Complexity994
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)


Radiation-Protective Agents

Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)


Antineoplastic Agents, Phytogenic

Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty